Literature DB >> 2895868

Subcutaneous apomorphine in Parkinson's disease.

W Poewe, B Kleedorfer, F Gerstenbrand, W Oertel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895868     DOI： 10.1016/s0140-6736(88)91755-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  The clinical use of apomorphine in Parkinson's disease.

Authors:  M J Steiger; N P Quinn; C D Marsden
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

3.  Subcutaneous and sublingual levodopa methyl ester in Parkinson's disease.

Authors:  B Kleedorfer; A J Lees; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

Review 4.  The modern management of Parkinson's disease.

Authors:  N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

Review 5.  The on-off phenomenon.

Authors:  A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

6.  [Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].

Authors:  C Trenkwalder; S Boesch; A Ceballos-Baumann; D Dressler; K Eggert; T Gasser; H Honig; T Müller; H Reichmann; J P Sieb; A Storch; P Odin; W Poewe
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

7.  Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease.

Authors:  F Durif; E Jeanneau; F Serre-Debeauvais; D Deffond; A Eschalier; M Tournilhac
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Efficacy of sublingual apomorphine in Parkinson's disease.

Authors:  F Durif; D Deffond; M Tournilhac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

9.  Comparison of motor response to apomorphine and levodopa in Parkinson's disease.

Authors:  P A Kempster; J P Frankel; G M Stern; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

Review 10.  Current status of dopamine agonists in Parkinson's disease management.

Authors:  J L Montastruc; O Rascol; J M Senard
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.